MDCO

Medicines Co

MDCO

Delisted

MDCO was delisted on the 3rd of January, 2020.

250 hedge funds and large institutions have $5.11B invested in Medicines Co in 2019 Q3 according to their latest regulatory filings, with 55 funds opening new positions, 108 increasing their positions, 58 reducing their positions, and 32 closing their positions.

2020 Q3 2020 Q2 2020 Q1 2019 Q4 2019 Q3 2019 Q2 2019 Q1 2018 Q4 2018 Q3 2018 Q2 2018 Q1 2017 Q4 2017 Q3 2017 Q2 2017 Q1 2016 Q4 2016 Q3 2016 Q2 2016 Q1 2015 Q4 2015 Q3 2015 Q2 2015 Q1 2014 Q4 2014 Q3 2014 Q2 2014 Q1 2013 Q4 2013 Q3 2013 Q2

Holders

250

Holders Change

+22

Holders Change %

+9.65%

% of All Funds

5.49%

Holding in Top 10

Holding in Top 10 Change

Holding in Top 10 Change %

+75%

% of All Funds

0.31%

New

Increased

108

Reduced

Closed

Calls

$489M

Puts

$586M

Net Calls

-$97.1M

Net Calls Change

-$1.83M

Top Buyers

1	1 Westfield Capital Management Boston, Massachusetts	$323M
2	2 BlackRock New York	$594M
3	3 Renaissance Technologies New York	$51.2M
4	4 Marshall Wace London, United Kingdom	$31.3M
5	HRCM 5 Hood River Capital Management Palm Beach Gardens, Florida	$30M

Top Sellers

1	1 Fidelity Investments Boston, Massachusetts	$469M
2	CCM 2 Camber Capital Management Boston, Massachusetts	$0
3	BM 3 Bridger Management New York	$70.4M
4	AH 4 Aviva Holdings New Providence, Bahamas	$5.76M
5	5 Bank of America Charlotte, North Carolina	$45.7M

#	Name	Market Value	Shares	Shares Change	Shares Change %
1	1 BlackRock New York	$594M	11,877,206	+945,080	+9%
2	2 Wellington Management Group Boston, Massachusetts	$553M	11,067,825	+107,739	+1%
3	3 Fidelity Investments Boston, Massachusetts	$469M	9,374,022	-1,481,780	-14%
4	4 Vanguard Group Malvern, Pennsylvania	$374M	7,474,698	+35,768	+0.5%
5	5 Westfield Capital Management Boston, Massachusetts	$323M	6,468,402	+1,821,394	+39%
6	SCM 6 Sarissa Capital Management Greenwich, Connecticut	$210M	4,202,000	–	–
7	MC 7 Maverick Capital Dallas, Texas	$194M	3,884,039	+16,956	+0.4%
8	SPC 8 Slate Path Capital New York	$185M	3,695,000	+150,000	+4%
9	9 State Street Boston, Massachusetts	$175M	3,508,265	-127,674	-4%
10	IAM 10 Iridian Asset Management Westport, Connecticut	$150M	3,001,362	-452,657	-13%
11	PI 11 Putnam Investments Boston, Massachusetts	$83.7M	1,673,357	-90,666	-5%
12	BM 12 Bridger Management New York	$70.4M	1,407,296	-906,718	-39%
13	AG 13 Artal Group Luxembourg	$70M	1,400,000	+400,000	+40%
14	14 Macquarie Group Sydney, NSW 2000, Australia	$55.9M	1,117,655	-146,687	-12%
15	15 Renaissance Technologies New York	$51.2M	1,024,732	+671,300	+190%
16	16 Geode Capital Management Boston, Massachusetts	$50.2M	1,004,232	+96,736	+11%
17	17 Northern Trust Chicago, Illinois	$48.1M	961,925	+89,020	+10%
18	18 Bank of New York Mellon New York	$45.9M	917,898	+43,179	+5%
19	19 Bank of America Charlotte, North Carolina	$45.7M	913,470	-833,188	-48%
20	RSCM 20 Rock Springs Capital Management Baltimore, Maryland	$40M	800,000	–	–
21	LPC 21 Lion Point Capital New York	$39.2M	783,950	+283,250	+57%
22	22 Ameriprise Minneapolis, Minnesota	$38.8M	775,571	-7,601	-1%
23	23 First Eagle Investment Management New York	$38.2M	764,012	+285,639	+60%
24	BC 24 Boxer Capital San Diego, California	$37.5M	750,000	–	–
25	25 Deutsche Bank Frankfurt Am Main Ge, Germany	$36.6M	732,977	+66,731	+10%

Medicines Co MDCO

Top Buyers

Top Sellers

Medicines Co

MDCO